These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 28683445

  • 1. Lysophosphatidylcholine Acyltransferase-3 Expression Is Associated with Atherosclerosis Progression.
    Tanaka H, Zaima N, Sasaki T, Yamamoto N, Inuzuka K, Yata T, Iwaki T, Umemura K, Sano H, Suzuki Y, Urano T, Setou M, Unno N.
    J Vasc Res; 2017; 54(4):200-208. PubMed ID: 28683445
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Deficiency in lysophosphatidylcholine acyltransferase 3 reduces plasma levels of lipids by reducing lipid absorption in mice.
    Li Z, Jiang H, Ding T, Lou C, Bui HH, Kuo MS, Jiang XC.
    Gastroenterology; 2015 Nov; 149(6):1519-29. PubMed ID: 26226572
    [Abstract] [Full Text] [Related]

  • 7. Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression.
    Morita Y, Sakaguchi T, Ikegami K, Goto-Inoue N, Hayasaka T, Hang VT, Tanaka H, Harada T, Shibasaki Y, Suzuki A, Fukumoto K, Inaba K, Murakami M, Setou M, Konno H.
    J Hepatol; 2013 Aug; 59(2):292-9. PubMed ID: 23567080
    [Abstract] [Full Text] [Related]

  • 8. Caspase-independent hepatocyte death: A result of the decrease of lysophosphatidylcholine acyltransferase 3 in non-alcoholic steatohepatitis.
    Kakisaka K, Suzuki Y, Fujiwara Y, Suzuki A, Kanazawa J, Takikawa Y.
    J Gastroenterol Hepatol; 2019 Jul; 34(7):1256-1262. PubMed ID: 30160786
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. β-Sarcoglycan Deficiency Reduces Atherosclerotic Plaque Development in ApoE-Null Mice.
    Murugesan V, Degerman E, Holmen-Pålbrink AK, Duner P, Knutsson A, Hultgårdh-Nilsson A, Rauch U.
    J Vasc Res; 2017 Jul; 54(4):235-245. PubMed ID: 28768281
    [Abstract] [Full Text] [Related]

  • 11. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
    Sahara M, Ikutomi M, Morita T, Minami Y, Nakajima T, Hirata Y, Nagai R, Sata M.
    Cardiovasc Res; 2014 Feb 01; 101(2):236-46. PubMed ID: 24193738
    [Abstract] [Full Text] [Related]

  • 12. Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion.
    Rong X, Wang B, Dunham MM, Hedde PN, Wong JS, Gratton E, Young SG, Ford DA, Tontonoz P.
    Elife; 2015 Mar 25; 4():. PubMed ID: 25806685
    [Abstract] [Full Text] [Related]

  • 13. Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.
    Jojima T, Uchida K, Akimoto K, Tomotsune T, Yanagi K, Iijima T, Suzuki K, Kasai K, Aso Y.
    Atherosclerosis; 2017 Jun 25; 261():44-51. PubMed ID: 28445811
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification and characterization of a major liver lysophosphatidylcholine acyltransferase.
    Zhao Y, Chen YQ, Bonacci TM, Bredt DS, Li S, Bensch WR, Moller DE, Kowala M, Konrad RJ, Cao G.
    J Biol Chem; 2008 Mar 28; 283(13):8258-65. PubMed ID: 18195019
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A meprin inhibitor suppresses atherosclerotic plaque formation in ApoE-/- mice.
    Gao P, Guo RW, Chen JF, Chen Y, Wang H, Yu Y, Huang L.
    Atherosclerosis; 2009 Nov 28; 207(1):84-92. PubMed ID: 19464686
    [Abstract] [Full Text] [Related]

  • 19. A novel assay for measuring recombinant human lysophosphatidylcholine acyltransferase 3 activity.
    Du X, Hu J, Zhang Q, Liu Q, Xiang X, Dong J, Lou B, He S, Gu X, Cao Y, Li Y, Ding T.
    FEBS Open Bio; 2019 Oct 28; 9(10):1734-1743. PubMed ID: 31376210
    [Abstract] [Full Text] [Related]

  • 20. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
    Butcher MJ, Waseem TC, Galkina EV.
    Arterioscler Thromb Vasc Biol; 2016 Aug 28; 36(8):1496-506. PubMed ID: 27365405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.